Actively hiring
Sports Medicine
Health Care
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
News
How Plants Rewind Their Cells: The Molecular Secrets of De Novo
Plants cannot run away from danger. Rooted in place, they endure herbivores, storms, pathogens, and physical injury, yet many can regrow an entire organism from a single detached leaf or stem fragment. This extraordinary talent, known as de novo organogen
Read more
Report
Report
Organogenesis Initiates BLA Submission For ReNu In Knee Arthritis
(RTTNews) - Organogenesis Holdings Inc. (ORGO) ,a regenerative medicine company announced that it has initiated the submission of a Biologics License Application or BLA to the US Food and Drug Administration or FDA for its lead amniotic suspension allogra
Read more
Report
Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation
CANTON, Mass., July 15, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgic
Read more
Report
Pro access
Upgrade to see all 14 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Tech stack
Technologies named in job postings at Organogenesis over the last 12 months, by layer, with the share of postings for each.
Technologies in use
1
Postings analysed
1
Stack modernity
64/100
Developer tools
AutoCAD
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$135k
Typical range
$125k – $145k
Open positions
2
2
Jobs
Junior
50%
Middle
50%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 1 | $145k | $145k |
| Middle | 1 | $125k | $125k |
Highest paying role
Compliance Counsel
$145k
Normalized to USD per year
People

Antonio Montecalvo
Executive Officer

Patrick Bilbo
Executive Officer

Robert Cavorsi
Executive Officer

Gary Gillheeney Sr.
Executive Officer, Director

Lori Freedman
Executive Officer

David Francisco
Executive Officer

Brian Grow
Executive Officer

Michele Korfin
Director

Michael Driscoll
Director

Jon Giacomin
Director

Prathyusha Duraibabu
Director

Arthur Leibowitz
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
28/100
Slowing
Open positions
2
0 opened / 0 closed in 30 days
ATS activity
Every ~6 hours
09/28/2026
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Legal
50% ▲
Operations
50% ▼
Offices
Where the company hires and what each office is for
Cities
5
Hiring now
1
Countries
1
Busiest office
Norwood
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Norwood
United States
Regional office
Norwood, Massachusetts
1 open roles 1 posted in 90 days $125k Avg Salary
hires for Operations
333 Providence Hwy, Norwood, MA 02062
San Diego
United States
Regional office
San Diego, California
3040 Science Park Rd, San Diego, CA 92121
Smithfield
United States
Regional office
Smithfield, Rhode Island
100 Technology Way, Smithfield, RI 02917
Birmingham
United States
Regional office
Birmingham, Alabama
2 Perimeter Park South, 350E, Birmingham, AL 35243
Financials
Total raised
$130M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2024 | $130M | Details |
